Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability.
about
Preparation, characterisation and evaluation of curcumin with piperine-loaded cubosome nanoparticles.Topical Ocular Drug Delivery to the Back of the Eye by Mucus-Penetrating Particles.Characterization of cubosomes as a targeted and sustained transdermal delivery system for capsaicin.Enhanced oral absorption of 20(S)-protopanaxadiol by self-assembled liquid crystalline nanoparticles containing piperine: in vitro and in vivo studies.Design and in vitro evaluation of finasteride-loaded liquid crystalline nanoparticles for topical delivery.Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation.Liquid Crystalline Nanoparticles as an Ophthalmic Delivery System for Tetrandrine: Development, Characterization, and In Vitro and In Vivo Evaluation.Ophthalmic delivery of brinzolamide by liquid crystalline nanoparticles: in vitro and in vivo evaluation.Ocular drug delivery - a look towards nanobioadhesives.Recent advances in ocular drug delivery.Novel strategies for anterior segment ocular drug delivery.Nanoparticles in the ocular drug delivery.Nanostructured liquid-crystalline particles for drug delivery.Nanocarriers for ocular delivery for possible benefits in the treatment of anterior uveitis: focus on current paradigms and future directions.Cubosomes and other potential ocular drug delivery vehicles for macromolecular therapeutics.Spotlight on Biomimetic Systems Based on Lyotropic Liquid Crystal.Quantitative analysis of matrine in liquid crystalline nanoparticles by HPLC.Development and characterization of novel hydrogel containing antimicrobial drug for treatment of burns.A novel eye drop of alpha tocopherol to prevent ocular oxidant damage: improve the stability and ocular efficacy.Evaluation of gatifloxacin pluronic micelles and development of its formulation for ocular delivery.Ocular delivery of cyclosporine A based on glyceryl monooleate/poloxamer 407 liquid crystalline nanoparticles: preparation, characterization, in vitro corneal penetration and ocular irritation.Enhanced topical delivery of finasteride using glyceryl monooleate-based liquid crystalline nanoparticles stabilized by cremophor surfactants.Self assembled materials: design strategies and drug delivery perspectives.Self-assembled liquid crystalline nanoparticles as an ophthalmic drug delivery system. Part I: influence of process parameters on their preparation studied by experimental design.Binary blend of glyceryl monooleate and glyceryl monostearate for magnetically induced thermo-responsive local drug delivery system.Novel cationic lipid nanoparticles as an ophthalmic delivery system for multicomponent drugs: development, characterization, in vitro permeation, in vivo pharmacokinetic, and molecular dynamics studies.Ocular Drug Delivery.Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases.Cubic liquid crystalline nanoparticles: optimization and evaluation for ocular delivery of tropicamide.Evaluation of subconjunctival liposomal steroids for the treatment of experimental uveitis.
P2860
Q35123608-859615BB-E9E2-47B5-AFC6-F20EC5EF06E5Q35759073-0DFF7327-CFCB-4D10-BF7E-1F36465426C6Q35765880-3E5B4E10-DA2E-423D-A708-440FD6A8F966Q36620613-10FD7895-C6A1-4069-9CE4-BBEE8C1A12E9Q36636516-EABDF7C0-55FE-49C9-96B2-D70C2741FF5EQ36852078-7349A2AF-B93D-4967-ABBF-079F8A3DC96DQ36910413-23B52BE2-D7B1-4AA3-9772-F418F9A57AF6Q37126415-C496CB2B-7931-4FC8-92E7-2F3F808298E4Q37822756-224B8FF2-368B-4D2A-8B07-2941CDB2A0FBQ38059884-4509C875-EFA3-4030-BC0A-AD2229388B4EQ38065184-866BCAC0-40AB-4550-A680-D23D503AFDFEQ38119238-C01F2C62-3B1D-4A26-A157-42008C32A709Q38184591-FE695067-9B7D-41AA-92B5-DBB1D1A166A0Q38227621-612903FC-6F28-4AD2-AEE8-0E65D60F996DQ38368715-A31F6CDB-36C3-4372-9894-196AD78B4A57Q38921324-A0956A7A-D562-44E9-B85A-25186399B59CQ39200110-6FBF7C30-60EA-4838-8CF1-D11DD1D95309Q40547678-41CF7A63-D65A-4D05-BCC8-9F2A7E4D83F5Q40573088-5217B311-A832-495F-AE98-097D8E6ADDBBQ41196940-024E8D82-4F32-41BC-913E-428D0A5BB44DQ41612480-1BDDC9B4-D6CF-4FCD-B633-5938E13D0EBFQ41904436-9E6DD95D-E7BF-45A8-A0E6-C3E66CA2BECEQ43975235-B5322AA3-12A6-479A-9CA5-599414495C06Q44774296-449B74C8-B18C-44BF-BAFE-6CFE6F670FCDQ46362081-B1E443CC-C6D2-402B-A441-639FFA7896ACQ47143814-504BFF4B-F5DD-495A-9358-52D0EE4CB013Q51122641-E0AAABC9-3884-4492-836A-79B85E6BA7A3Q52679059-76B1C035-D710-473E-AFE5-32A0F578D7AFQ53174701-64375F6E-A4D1-4F82-8347-F767B3A7CEE5Q55176472-34221579-C1A6-49BC-B9C9-1185EC2D41A3
P2860
Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Self-assembled liquid crystall ...... on and ocular bioavailability.
@en
Self-assembled liquid crystall ...... on and ocular bioavailability.
@nl
type
label
Self-assembled liquid crystall ...... on and ocular bioavailability.
@en
Self-assembled liquid crystall ...... on and ocular bioavailability.
@nl
prefLabel
Self-assembled liquid crystall ...... on and ocular bioavailability.
@en
Self-assembled liquid crystall ...... on and ocular bioavailability.
@nl
P2093
P921
P1476
Self-assembled liquid crystall ...... on and ocular bioavailability.
@en
P2093
Chunliu Zhu
Jinqiu Shen
Xinxin Zhang
P304
P356
10.1016/J.IJPHARM.2010.06.015
P407
P577
2010-06-15T00:00:00Z